These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 22819178)
21. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. Pickles MD; Gibbs P; Sreenivas M; Turnbull LW J Magn Reson Imaging; 2006 Feb; 23(2):130-4. PubMed ID: 16374882 [TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution. Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894 [TBL] [Abstract][Full Text] [Related]
23. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. Hosseinzadeh K; Schwarz SD J Magn Reson Imaging; 2004 Oct; 20(4):654-61. PubMed ID: 15390142 [TBL] [Abstract][Full Text] [Related]
24. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Mulkern RV; Barnes AS; Haker SJ; Hung YP; Rybicki FJ; Maier SE; Tempany CM Magn Reson Imaging; 2006 Jun; 24(5):563-8. PubMed ID: 16735177 [TBL] [Abstract][Full Text] [Related]
25. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373 [TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences. Kozlowski P; Chang SD; Goldenberg SL Magn Reson Imaging; 2008 Jan; 26(1):72-6. PubMed ID: 17566687 [TBL] [Abstract][Full Text] [Related]
27. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761 [TBL] [Abstract][Full Text] [Related]
28. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer. Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286 [TBL] [Abstract][Full Text] [Related]
29. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer. Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283 [TBL] [Abstract][Full Text] [Related]
30. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. Kim JH; Kim JK; Park BW; Kim N; Cho KS J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000 [TBL] [Abstract][Full Text] [Related]
31. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. Song I; Kim CK; Park BK; Park W AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065 [TBL] [Abstract][Full Text] [Related]
32. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging. Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522 [TBL] [Abstract][Full Text] [Related]
33. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519 [TBL] [Abstract][Full Text] [Related]
35. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056 [TBL] [Abstract][Full Text] [Related]
36. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002 [TBL] [Abstract][Full Text] [Related]
37. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. Kim CK; Park BK; Kim B AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference. Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596 [TBL] [Abstract][Full Text] [Related]
39. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890 [TBL] [Abstract][Full Text] [Related]
40. Diffusion-attenuated MRI signal of renal allografts: comparison of two different statistical models. Blondin D; Lanzman RS; Klasen J; Scherer A; Miese F; Kröpil P; Wittsack HJ AJR Am J Roentgenol; 2011 Jun; 196(6):W701-5. PubMed ID: 21606257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]